IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma
Clinical trial NCT01491841 · COMPLETED
Trial details
- NCT number
- NCT01491841
- Sponsor
- Anne Beaven, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2016-11-22
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.